The Top Five Global Pharma Companies; Where they are Now and Where they are Heading

Table of Contents

• The Who, What, Where, How and Why of this Report
• Key Take-Aways
  • Table 1: Which Top Five Global Pharma are Chosen?
  • Chart 1: Net Income per Employee against R&D Expenditures
• Johnson & Johnson Case Study
  • Table 2: J&J' s New Medical Entity Filings 2007-2010
• Pfizer Case Study
  • Table 3: Pfizer' s New Medical Entity Filings 2010 and Beyond
• GlaxoSmithKline Case Study
  • Table 4: Sales & Success Estimates for GSK' s Early Phase-Clinically Superior Pipeline
• Novartis Case Study
  • Table 5: Novartis' Scheduled NME Filings from 2008 to Beyond 2011
• Sanofi-Aventis Case Study
  • Table 6: Sanofi-Aventis' Short-Term NME Filings
  • Table 7: PEG Ratio Valuation
  • Chart 2: PEG Ratio Valuation
  • Table 8: BCG Analysis
  • Chart 3: BCG Matrix of Global Pharma
• Interpretation of BCG Matrix (Chart 3)
• Appendix - Financial Terminology
• Disclaimer